A nurse is assessing a client who is receiving intravenous therapy. The nurse should
identify which of the following findings as a manifestation of fluid volume excess?
B. Distended neck veins
A nurse is caring for a client who has hyponatremia and is receiving an infusion of a
prescribed hypertonic solution. Which of the following findings should indicate to the
nurse that the treatment is effective? b. Improved cognition
A nurse is teaching a client who has a new prescription for a nitroglycerin transdermal
patch. Which of the following instructions should the nurse include?
D. "Remove the patch prior to going to bed."
A nurse is reviewing he laboratory results of a client who has a prescription for sodium
polystyrene sulfonate (Kayexalate) every 6 hr. which of the following should the nurse
report to the provider? D. Potassium 5.2 mEq/L Hyperkalemia (serum potassium level
greater than 5.0 mEq/L) increases the client risk for fatal cardiac dysrhythmias.
Kayexalate is used to decrease the serum potassium level, so the PN should monitor
the client's serum potassium level
A nurse is caring for a client who has tuberculosis and is taking isoniazid and rifampin.
Which of the following outcomes indicates that the client is adhering to the medication
regimen? a. The client has a negative sputum culture
A nurse is caring for a client who develops an anaphylactic reaction to IV administration.
After assessing the client's respiratory status and stopping the medication infusion.
Which of the following actions should the nurse take next? D. Administer epinephrine IM
A nurse is caring for a client who is taking sertraline and reports a desire to begin taking
supplements. Which of the following supplements should the nurse advise the client to
avoid? a. St. John's Wort
A nurse is caring for a client who has heart failure and a new prescription for lisinopril.
For which of the following adverse effects should the nurse monitor when administering
lisinopril? d. Hypotension
Category | ATI EXAM |
Comments | 0 |
Rating | |
Sales | 0 |